SC 13G

NAME OF REPORTING PERSON

Norwest Venture Partners XI, LP

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐ (b) ☐

SEC USE ONLY

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

SC 13G 1 d124230dsc13g.htm SC 13G SC 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Health Catalyst, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

42225T107

(CUSIP Number)

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

13G

CUSIP NO. 42225T107

13G

CUSIP NO. 42225T107

13G

CUSIP NO. 42225T107

13G

CUSIP NO. 42225T107

13G

CUSIP NO. 42225T107

13G

CUSIP NO. 42225T107

13G

CUSIP NO. 42225T107

13G

CUSIP NO. 42225T107

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

Item 1(a)

Name of Issuer:

Health Catalyst, Inc.

Item 1(b)

Address of Issuer’s Principal Executive Offices:

3165 Millrock Drive, #400

Salt Lake City, UT 84121

Item 2(a)

Name of Person Filing:

Norwest Venture Partners XI, LP

Genesis VC Partners XI, LLC

Norwest Venture Partners XII, LP

Genesis VC Partners XII, LLC

NVP Associates, LLC

Promod Haque

Jeffrey Crowe

Jon E. Kossow

Item 2(b)

Address of Principal Business Office or, if None, Residence:

Norwest Venture Partners XI, LP

525 University Ave, Suite 800

Palo Alto, CA 94301

Genesis VC Partners XI, LLC

525 University Ave, Suite 800

Palo Alto, CA 94301

Norwest Venture Partners XII, LP

525 University Ave, Suite 800

Palo Alto, CA 94301

Genesis VC Partners XII, LLC

525 University Ave, Suite 800

Palo Alto, CA 94301

NVP Associates, LLC

525 University Ave, Suite 800

Palo Alto, CA 94301

Promod Haque

525 University Ave, Suite 800

Palo Alto, CA 94301

Jeffrey Crowe

525 University Ave, Suite 800

Palo Alto, CA 94301

Jon E. Kossow

525 University Ave, Suite 800

Palo Alto, CA 94301

This statement is filed by Norwest Venture Partners XI, LP on its own behalf and on behalf of (a) Genesis VC Partners XI, LLC, (b) Norwest Venture Partners XII, LP, (c) Genesis VC Partners XII, LLC, (d) NVP Associates, LLC, (e) Promod Haque, (f) Jeffrey Crowe and (g) Jon E. Kossow pursuant to Rule 13d-1(d) and Rule 13d-1(k). Norwest Venture Partners XI, LP is a Delaware limited partnership, whose general partner is Genesis VC Partners XI, LLC. Norwest Venture Partners XII, LP is a Delaware limited partnership, whose general partner is Genesis VC Partners XII, LLC. NVP Associates, LLC is the managing member of Genesis VC Partners XI, LLC and Genesis VC Partners XII, LLC. Promod Haque, Jeffrey Crowe and Jon E. Kossow are co-Chief Executive Officers of NVP Associates, LLC.

Item 2(c)

Citizenship:

Norwest Venture Partners XI, LP: Delaware

Genesis VC Partners XI, LLC: Delaware

Norwest Venture Partners XII, LP: Delaware

Genesis VC Partners XII, LLC: Delaware

NVP Associates, LLC: Delaware

Promod Haque: United States of America

Jeffrey Crowe: United States of America

Jon E. Kossow: United States of America

Item 2(d)

Title of Class of Securities:

Common Stock

Item 2(e)

CUSIP Number:

42225T107

Item 3

Not Applicable

Item 4

Ownership:

(1) Norwest Venture Partners XI, LP (“NVP XI”): At December 31, 2020, NVP XI owned of record 0 shares of Issuer’s common stock (“Common Stock”). This amount represents 0% of the total shares of Common Stock outstanding at this date.

(2) Genesis VC Partners XI, LLC (“Genesis XI”): At December 31, 2020, Genesis XI may be deemed to have beneficially owned, by virtue of its status as general partner of NVP XI, 0 shares of Common Stock. This amount represents 0% of the total shares of Common Stock outstanding at this date.

(3) Norwest Venture Partners XII, LP (“NVP XII”): At December 31, 2020, NVP XII owned of record 0 shares of Issuer’s Common Stock. This amount represents 0% of the total shares of Common Stock outstanding at this date.

(4) Genesis VC Partners XII, LLC (“Genesis XII”): At December 31, 2020, Genesis XII may be deemed to have beneficially owned, by virtue of its status as general partner of NVP XII, 0 shares of Common Stock. This amount represents 0% of the total shares of Common Stock outstanding at this date.

(5) NVP Associates, LLC (“NVP Associates”): At December 31, 2020, NVP Associates may be deemed to have beneficially owned 0 shares of Common Stock consisting of the following: (1) (0) shares of Common Stock by virtue of its status as managing member of Genesis XI, the general partner of NVP XI, the record owner of such shares; and (2) (0) shares of Common Stock by virtue of its status as managing member of Genesis XII, the general partner of NVP XII, the record owner of such shares. This amount represents 0% of the total shares of Common Stock outstanding at this date.

(6) Promod Haque: At December 31, 2020, Promod Haque may be deemed to have beneficially owned 0 shares of Common Stock consisting of the following: (1) (0) shares of Common Stock by virtue of his status as co-Chief Executive Officer of NVP Associates, the managing member of Genesis XI, the general partner of NVP XI, the record owner of such shares; and (2) (0)shares of Common Stock by virtue of his status as co-Chief Executive Officer of NVP Associates, the managing member of Genesis XII, the general partner of NVP XII, the record owner of such shares. This amount represents 0% of the total shares of Common Stock outstanding at this date.

(7) Jeffrey Crowe: At December 31, 2020, Jeffrey Crowe may be deemed to have beneficially owned 0 shares of Common Stock consisting of the following: (1) (0) shares of Common Stock by virtue of his status as co-Chief Executive Officer of NVP Associates, the managing member of Genesis XI, the general partner of NVP XI, the record owner of such shares; and (2) (0) shares of Common Stock by virtue of his status as co-Chief Executive Officer of NVP Associates, the managing member of Genesis XII, the general partner of NVP XII, the record owner of such shares. This amount represents 0% of the total shares of Common Stock outstanding at this date.

(8) Jon E. Kossow: At December 31, 2020, Jon E. Kossow may be deemed to have beneficially owned 0 shares of Common Stock consisting of the following: (1) (0) shares of Common Stock by virtue of his status as co-Chief Executive Officer of NVP Associates, the managing member of Genesis XI, the general partner of NVP XI, the record owner of such shares; and (2) (0) shares of Common Stock by virtue of his status as co-Chief Executive Officer of NVP Associates, the managing member of Genesis XII, the general partner of NVP XII, the record owner of such shares. This amount represents 0% of the total shares of Common Stock outstanding at this date.

Item 5

Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting persons have ceased to be beneficial owners of more than five percent of the class of securities, check the following [X].

Item 6

Ownership of More than Five Percent on Behalf of Another Person:

Not Applicable

Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not Applicable

Item 8

Identification and Classification of Members of the Group:

Not Applicable

Item 9

Notice of Dissolution of Group:

Not Applicable

Item 10

Certification:

Not applicable

Signature.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.

Date: February 12, 2021

NORWEST VENTURE PARTNERS XI, LP

By	Genesis VC Partners XI, LLC, as general partner

By	NVP Associates, LLC, as managing member


By:		/s/ Matthew De Dominicis
		Matthew De Dominicis, Chief Financial Officer

AGREEMENT

The undersigned hereby agree that this Schedule 13G to which this Agreement is attached shall be filed by Norwest Venture Partners XI, LP on its own behalf and on behalf of (a) Genesis VC Partners XI, LLC, a Delaware limited liability company, (b) Norwest Venture Partners XII, LP, a Delaware limited partnership, (c) Genesis VC Partners XII, LLC, a Delaware limited liability company, (d) NVP Associates, LLC, a Delaware limited liability company, (e) Promod Haque, (f) Jeffrey Crowe and (g) Jon E. Kossow.

Dated: February 12, 2021

Norwest Venture Partners XI, LP

By	Genesis VC Partners XI, LLC, as general partner

By	NVP Associates, LLC, as managing member


By:		/s/ Matthew De Dominicis
		Matthew De Dominicis, Chief Financial Officer

Genesis VC Partners XI, LLC

By	NVP Associates, LLC, as managing member


By:		/s/ Matthew De Dominicis
		Matthew De Dominicis, Chief Financial Officer

Norwest Venture Partners XII, LP

By	Genesis VC Partners XII, LLC, as general partner

By	NVP Associates, LLC, as managing member


By:		/s/ Matthew De Dominicis
		Matthew De Dominicis, Chief Financial Officer

Genesis VC Partners XII, LLC

By	NVP Associates, LLC, as managing member


By:		/s/ Matthew De Dominicis
		Matthew De Dominicis, Chief Financial Officer

NVP Associates, LLC


By:		/s/ Matthew De Dominicis
		Matthew De Dominicis, Chief Financial Officer

/s/ Matthew De Dominicis

Matthew De Dominicis, as Attorney-in-fact for Promod Haque

/s/ Matthew De Dominicis

Matthew De Dominicis, as Attorney-in-fact for Jeffrey Crowe

/s/ Matthew De Dominicis

Matthew De Dominicis, as Attorney-in-fact for Jon E. Kossow

SEC Form SC 13G filed